ASP Isotopes COO Sells $117K in Shares

Insider sale comes after Q1 earnings miss and concerns over company's financials

Apr. 18, 2026 at 11:26am

Got story updates? Submit your updates here. ›

An extreme close-up of intricate, heavy industrial machinery and equipment used in the production of isotopes, conveying a sense of secure, tangible financial assets without literal currency or charts.The insider sale of ASP Isotopes stock by the company's COO comes amid concerns over the firm's financial performance and future prospects.Washington Today

ASP Isotopes Inc. (NASDAQ:ASPI) Chief Operating Officer Robert Ainscow sold 22,500 shares of the company's stock on April 16th, netting $117,225. The sale was to cover tax withholding obligations related to vested equity awards, leaving Ainscow with 1,490,317 shares, a 1.49% reduction in his ownership stake.

Why it matters

The insider sale comes after ASP Isotopes reported a significant earnings miss in Q1, with EPS of ($0.84) versus a ($0.14) consensus, despite beating revenue expectations. The company also has very large negative profit margins and a negative return on equity, raising concerns about its financial health and future prospects.

The details

Ainscow's sale of 22,500 shares at an average price of $5.21 represents a transaction value of $117,225. Following the sale, Ainscow still owns 1,490,317 shares, a 1.49% reduction in his overall stake. The insider transaction was disclosed in a legal filing with the SEC.

  • The share sale occurred on Thursday, April 16, 2026.

The players

Robert Ainscow

Chief Operating Officer of ASP Isotopes Inc.

ASP Isotopes Inc.

A development stage advanced materials company focused on the production and commercialization of isotopes.

Got photos? Submit your photos here. ›

What they’re saying

“The sale was made to cover tax withholding obligations related to the vesting of equity awards.”

— Robert Ainscow, Chief Operating Officer

What’s next

Investors will be closely watching ASP Isotopes' future financial performance and any additional insider trading activity to gauge the company's outlook.

The takeaway

The insider sale by ASP Isotopes' COO, coupled with the company's weak Q1 results, raises concerns about the firm's financial health and long-term viability, despite its ambitious plans in the isotopes market.